The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Cell & Gene Therapy Core

Cells, gene-editing, plasmid and vector tools for your research.

As of the first of January 2022  StemTherapy and Multipark have decided to merge the former iPSC, CRISPR and vector platforms into the new Cell and Gene Therapy Core. 

The Cell and Gene Therapy core is an open-access infrastructure and our services include AAV and LV vector production, cloning services, iPS reprogramming, iPS-edits and CRISPR experimental designs. The core is open to members of the SCC as well as national and international users.

CAGT core logo

We are a state-of-the art unit that can provide complete services from idea to finished products. We will aid in design of the project and its constituents (e.g. gRNA and plasmids), the manufacture or purchase of required components (e.g., plasmids, viruses, Cas9), cell manipulation (gene-edits, transduction, reprogramming, selection), cell harvest and differentiation into other cell types (service in progress). We will also offer partial services and access to gene editing and iPS-facilities, depending on individual needs.

We look forward to working with you to create the tools for your research !

 

 

Contact information

Email: cellandgenetherapy [at] med [dot] lu [dot] se

Coordinator: Pia Johansson, BMC B1018b

News from the Core


Wed May 11th,  Core OPEN DAY

Time: 13.00-15.30 at BMC B10

Come and visit!!! Chat, eat cake, take a quiz, win a prize. 

Sign up for CRISPR talks and iPS talks

Hope to see you there! 


 

group picture
logos